Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Joel A. Nations"'
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 11, p 3217 (2024)
Background: Lung cancer is one of the most lethal cancers with survival being closely related to stage and influenced by comorbid illness. The survival implications of pulmonary hypertension (PH) on patients with non-small cell lung cancer (NSCLC) ha
Externí odkaz:
https://doaj.org/article/536772dfec694f1c80fb51a4413ce4b8
Autor:
Charles Faselis, Joel A. Nations, Charity J. Morgan, Jared Antevil, Jeffrey M. Roseman, Sijian Zhang, Gregg C. Fonarow, Helen M. Sheriff, Gregory D. Trachiotis, Richard M. Allman, Prakash Deedwania, Qing Zeng-Trietler, Daniel D. Taub, Amiya A. Ahmed, George Howard, Ali Ahmed
Publikováno v:
JAMA Oncol
ImportanceThe US Preventive Services Task Force does not recommend annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years who are former smokers with 20 or more pack-years of smoking who quit 15 or more y
Autor:
Kangmin Zhu, Craig D. Shriver, William F. Anderson, Joel A. Nations, Corey A. Carter, Katherine A. McGlynn, Jie Lin
Supplemental Figure 1. Kaplan-Meier survival curves comparing non-small cell lung cancer (NSCLC) patients with and without pre-existing mental health disorders. NSCLC was diagnosed between 1998 and 2007.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82323e4d58c6eca66adc560a9149604c
https://doi.org/10.1158/1055-9965.22438654
https://doi.org/10.1158/1055-9965.22438654
Autor:
Kangmin Zhu, Craig D. Shriver, William F. Anderson, Joel A. Nations, Corey A. Carter, Katherine A. McGlynn, Jie Lin
Background: Higher cancer-related mortality has been observed among people with mental health disorders than in the general population. Both delay in diagnosis and inadequate treatment due to health care access have been found to explain the higher m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a38515d657497c646a9a7cb84c0ba6c
https://doi.org/10.1158/1055-9965.c.6516463.v1
https://doi.org/10.1158/1055-9965.c.6516463.v1
Autor:
Kangmin Zhu, Craig D. Shriver, William F. Anderson, Joel A. Nations, Corey A. Carter, Katherine A. McGlynn, Jie Lin
This is the legend of the supplementary figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc5574d02a1f1444c7fb856dd360ec7
https://doi.org/10.1158/1055-9965.22438657.v1
https://doi.org/10.1158/1055-9965.22438657.v1
Publikováno v:
Military Medicine. 185:e2044-e2048
Introduction We compared the stage at diagnosis for non-small cell lung cancer (NSCLC) patients in the military healthcare system (MHS) and the general public to assess differences between these two groups as well as to assess the trends in stage at
Publikováno v:
Cancer Causes Control
PURPOSE: We investigated the association between comorbidities and stage at diagnosis among NSCLC patients in the U.S. Military Health System (MHS), which provides universal health care to its beneficiaries. METHODS: The linked data from the Departme
Autor:
P Gabriel Peterson, Stephanie R. Land, Rebecca A. Ferrer, Robert A. Liotta, Paul K. J. Han, Megan C. Roberts, William M. P. Klein, Elizabeth L. Seaman, Hormuzd A. Katki, Joel A. Nations
Publikováno v:
J Cancer Educ
Researchers at the NCI have developed the Risk-Based NLST Outcomes Tool (RNOT), an online tool that calculates risk of lung cancer diagnosis and death with and without lung cancer screening, and false-positive risk estimates. This tool has the potent
Autor:
Joel A. Nations, Katherine A. McGlynn, Derek Brown, Craig D. Shriver, Kangmin Zhu, Jie Lin, Christine Kamamia, Stephanie Shao, Corey A. Carter
Publikováno v:
Annals of epidemiology. 64
Purpose : The U.S. military health system provides universal health care access to beneficiaries. However, whether the universal access has translated into improved patient outcome is unknown. We compared survival of small-cell lung cancer patients i
Autor:
Kangmin Zhu, Craig D. Shriver, William F. Anderson, Jie Lin, Shelia Hoar Zahm, Katherine A. McGlynn, Corey A. Carter, Joel A. Nations, Abegail A. Gill
Publikováno v:
International Journal of Cancer. 141:254-263
Research suggests that metformin may be associated with improved survival in cancer patients with type II diabetes. This study assessed whether metformin use after non-small cell lung cancer (NSCLC) diagnosis is associated with overall survival among